These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 13398003)

  • 1. [Ambulant therapy of diabetics with hypoglycemic sulfonamide (BZ 55, nadisan, invenol)].
    HOFSTETTER JR; RAMEL C
    Helv Med Acta; 1956 Nov; 23(4-5):485-9. PubMed ID: 13398003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 3. [D 860 (rastinon) and BZ 55 (invenol) in oral therapy of diabetes mellitus].
    MELZER H; SACHSSE B
    Arztl Wochensch; 1956 Nov; 11(48):1058-62. PubMed ID: 13394470
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of hypoglycemic coma in invenol therapy of diabetes mellitus].
    MELLANDER R
    Sven Lakartidn; 1957 Feb; 54(7):450-3. PubMed ID: 13422300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypoglycemic coma in diabetics treated with sulfabutyl urea (BZ 55)].
    BUTTARO CA; TRAMONTANA C; GUAITINI V
    Riforma Med; 1957 Apr; 71(16):441-2. PubMed ID: 13442477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of ten cases of diabetes with oral hypoglycemic sulfonamide BZ 55 or nadisan].
    FERNANDEZ BASABE E; GALAN J; OLIVER A; OLIVER-PASCUAL E; PURAS E
    Rev Esp Enferm Apar Dig Nutr; 1956; 15(2):478-88. PubMed ID: 13370980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of the hypoglycaemic action of BZ 55 (invenol)].
    HERNANDEZ JAUREGUI R
    Medicina (Mex); 1957 Feb; 37(765):49-52. PubMed ID: 13407326
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary study on the use of a new hypoglycemic drug, invenol, by oral route].
    ROJAS F; BRAILOSKY D; SAAVEDRA J; DOONER H; PEIRANO P; ROMERO M
    Rev Med Chil; 1956 Aug; 84(8):408-11. PubMed ID: 13408725
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of diabetes mellitus with nadisan in the clinic and in practice].
    BUSER M
    Helv Med Acta; 1956 Nov; 23(4-5):471-9. PubMed ID: 13398000
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with peroral administration of antidiabetic drug BZ-55 (invenol)].
    BRESGEN C
    Med Klin; 1956 Jul; 51(29):1224-7. PubMed ID: 13358484
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism].
    PFEFFER KH; FUCHS KJ; MICHEL W; FOERDER HK
    Arztl Wochensch; 1957 Mar; 12(12):260-3. PubMed ID: 13410706
    [No Abstract]   [Full Text] [Related]  

  • 12. [A brief contribution on cutaneous side effects of the oral antidiabetic remedy BZ 55 (nadisan)].
    WALTHER H; WALZ H
    Ther Ggw; 1956 May; 95(5):183-4. PubMed ID: 13352317
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of invenol on the carbohydrate and protein metabolism in diabetes mellitus.
    MUTING D
    Arztl Wochensch; 1957 Jan; 12(4):77-81. PubMed ID: 13402606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with a new hypoglycemic sulfonamide derivative].
    TISZAI A; SZUCS Z
    Orv Hetil; 1957 May; 98(21):546-9. PubMed ID: 13452524
    [No Abstract]   [Full Text] [Related]  

  • 15. Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period.
    KERLAN M
    J Tn State Med Assoc; 1957 Feb; 50(2):46-8. PubMed ID: 13399061
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary experiences with the sulfonamide nadisan in therapy of diabetes].
    BROGLIE M; VOSS G; BERG EG; RUHLING O
    Medizinische; 1956 Apr; (17):656-9. PubMed ID: 13321484
    [No Abstract]   [Full Text] [Related]  

  • 17. [The current place of hypoglycemic sulfonamides (BZ 55) and similar products (D 860) in diabetic control].
    BASTENIE PA
    Brux Med; 1957 Mar; 37(13):499-506. PubMed ID: 13426651
    [No Abstract]   [Full Text] [Related]  

  • 18. [BZ 55 and D 860 in therapy of diabetes mellitus].
    BALDUINI M; BOARI L
    Boll Soc Med Chir Cremona; 1956; 11(1):37-53. PubMed ID: 13412973
    [No Abstract]   [Full Text] [Related]  

  • 19. [First experiences with the new oral antidiabetic invenol].
    FIALA E; BALASSA M
    Orv Hetil; 1957 May; 98(21):554-5. PubMed ID: 13452526
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of a hypoglycemic sulfonamide derivative (BZ 55) on the effectiveness of insulin in diabetics].
    BARTELHEIMER H; MARING H
    Klin Wochenschr; 1956 Oct; 34(37-38):1011-6. PubMed ID: 13377627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.